BRAFMutation Status in Gastrointestinal Stromal Tumors-Reference-Cited by-同舟云学术

BRAFMutation Status in Gastrointestinal Stromal Tumors

Published:2010-01 Issue:1 Volume:133 Page:141-148
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Hostein Isabelle,Faur Nicolas,Primois Charlotte,Boury Frédérique,Denard Jérome,Emile Jean-François,Bringuier Pierre-Paul,Scoazec Jean-Yves,Coindre Jean-Michel

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/133/1/141/5007217/ajcpath133-0141.pdf

Reference29 articles.

1. Molecular Analysis of c-KitandPDGFRAin GISTs Diagnosed by EUS

2. PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors

3. Mutations in gastrointestinal stromal tumors ? a population-based study from Northern Norway

4. Duensing A Medeiros F McConarty B Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs). Oncogene. 2004;13:3999–4006.

5. Signal transduction by several KIT juxtamembrane domain mutations

Cited by 184 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrointestinal stromal tumors with an uncommon primary mutation responded well to imatinib;Cancer Pathogenesis and Therapy;2024-08

2. Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors;Cancers;2024-04-27

3. Molecular and clinicopathological features of KIT/PDGFRAwild‐type gastrointestinal stromal tumors;Cancer Science;2024-01-05

4. Molecular pathology of gastrointestinal stromal tumors;Diagnostic Molecular Pathology;2024

5. Gastrointestinal Malignancy: Genetic Implications to Clinical Applications;Cancer Treatment and Research;2024